Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Benicar Lawsuit Filed Over Chronic Diarrhea, Instesinal Problems March 10, 2014 Irvin Jackson Add Your Comments A product liability lawsuit has been filed against Forest Laboratories and Daiichi Sankyo by a Texas man who alleges that he suffered severe intestinal problems from side effects of Benicar, which caused him to have chronic diarrhea that required hospitalization for more than 100 days. The complaint (PDF) was filed last month by George Edward William and his wife Martha. It was originally brought in the Superior Court of New Jersey for Atlantic County, but the drug makers have since removed the case to the U.S. District Court for the District of New Jersey. According to allegations raised in the Benicar lawsuit, Williams suffered chronic diarrhea, dehydration, weight loss, nausea, vomiting and malnutrition over a period of several years while taking the hypertension medication. Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Because doctors were unaware of the link between Benicar and intestinal problems, Williams was hospitalized more than 10 times over the last four years, spending more than 100 days in the hospital as doctors tried to figure out the cause of his problems. As a result, he claims that he has suffered a back fracture and cataracts on his eyes due to the side effect effects of steroids he was given to combat the mystery ailment, and has been left with permanent damage to his intestines that now requires him to use a feeding tube. In July 2013, the FDA issued a drug safety communication informing consumers and the medical community for the first time about the link between Benicar and sprue-like enteropathy, which causes chronic diarrhea, weight gain and other gastrointestinal problems. Federal health regulators indicated that users may develop symptoms that begin months or even years after the patients first started the treatment regimen. Those warnings came nearly a year after a study was published in the medical journal Mayo Clinic Proceedings, which highlighted reports of 22 cases of Benicar patients suffering symptoms similar to Celiac disease, which affects the small intestines. In many cases, Celiac disease patients are placed on a gluten free diet, as was Williams, but their problems continued. However, when Benicar was discontinued, the chronic diarrhea stopped. Williams claims that Daiichi Sankyo and Forest Laboratories knew or should have known about the risk of Benicar enteropathy problems, yet withheld information from consumers and the medical community. The lawsuit also claims that the manufacturers failed to conduct adequate studies on the long-term efficacy and risks associated with the Benicar. Although physicians commonly prescribe Benicar as treatment for hypertension for prolonged periods of six months to a year or more, clinical trials for the drug lasted only three months, according to the complaint. Benicar Risks Benicar belongs to a class of drugs known as angiotensin II recepbor blockers (ARBs). It is approved for the treatment of high blood pressure. The FDA also investigated it in 2010 for possible increased risks of cardiac death, but found none. The agency also investigated Benicar for links to cancer. The lawsuit accuses Daiichi Sankyo of overly-aggressive marketing of the drug, noting that the company spent $1 billion on promotional spending from 2002 to 2008, calling it an “ARB with superior efficacy.” But in 2006, the FDA determined that the efficacy and safety claims were unsubstantiated and accused the company of putting out false and misleading statements, noting that the marketing information failed to include important Benicar health risk information. In 2013, the FDA cited the company a second time for direct mail ads for Benicar, finding that the company was again making misleading statements and unsubstantiated claims about the blood pressure medication. There were an estimated 10.6 million prescriptions for Benicar or Benicar HCT in 2012, and a growing number of former users are now considering potential Benicar lawsuits after experience chronic diarrhea and gastrointestinal problems in recent years. Tags: Benicar, Daiichi Sankyo, Forest Laboratories, Hypertension Image Credit: | More Benicar Lawsuit Stories Benicar Recall Urged in FDA Petition Filed by Public Citizen December 8, 2017 Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017 Benicar Lawsuits Over Diarrhea, Gastrointestinal Problems Filed By Nearly 2,000 July 17, 2017 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)